43 news items
FDA Grants Priority Review to Merck's Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
MRK
29 May 24
Every day, we follow the science as we work to discover innovations that can help patients, no matter what stage of cancer
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
BIIB
MRK
29 May 24
unique and differentiated investment model of selecting high-quality and innovative assets that meets the strong Pharma demand and delivers value
Merck to Acquire EyeBio
MRK
29 May 24
therapies that combine scientifically robust targets with innovative translational approaches. To date, EyeBio has raised $130 million. SV Health
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
ABBV
JNJ
LLY
29 May 24
innovative approach to antiviral treatments. The company’s unique nanomedicine technology is designed to directly attack and dismantle viruses, which
Merck Announces Third-Quarter 2024 Dividend
MRK
28 May 24
innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce
i7atfp1n8v88v
MRK
28 May 24
innovations that can help patients, no matter what stage of cancer they have. As a leading oncology company, we are pursuing research where
14ilxm
AZN
GSK
MRK
27 May 24
funds domestically due to a stock market slump and a pricing regime overhaul that forces them to drop prices of innovative drugs.
Helen
uy2s9zyak8h2cdw2cj7y6f6xesiuztgil5mw1q
AMGN
BNTX
MRK
24 May 24
the treatment landscape, offering patients innovative and improved cancer therapies. This pivotal event highlights the ongoing momentum in oncology
jo6n7x8cwm783uwwkk5iez0 758hs5we09lhzop328gqlq4umjqrjf9
ABBV
JNJ
LLY
21 May 24
to a recent press release, the company's presentation will focus on its innovative cancer therapies, including the progress of its lead candidate
xdy8ns 389j7fhi
AZN
BAYRY
GSK
16 May 24
Sanofi gained access to Novavax’s innovative vaccine technology is one of the ways the French company is trying to find new growth avenues amid
64ihr0dpv539kqrcamfjtarirl98rgn8copwqp2ljlefi8mr62cgmll
MRK
15 May 24
our efforts to drive innovations that have potential to shape the future of oncology," said Dr. Marjorie Green, senior vice president and head
qs14pi6f5wwfv4f9znxwjztp6ar0euvnb 2vosdtlt
ANIP
LGND
MRK
14 May 24
monotherapy and combination studies. Merck is also working on different strategies to drive the long-term growth of Keytruda. These include innovative
0li65aq03giepoiyf929ko9dhqwo7scbir2gh
MRK
13 May 24
Our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer worldwide. At Merck, the potential to bring
vefxohur0e jx3lbv24rmmtp
MRK
9 May 24
are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster
bd2smyr4zd6pnjykd4y1pqgneswu0egzvi2p999cfqiud
MRK
9 May 24
Our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer worldwide. At Merck
l15lvrdzp5p8d72ed8qpy5 r711wvwxi
AZN
MRK
MRNA
8 May 24
collaboratively to develop innovative therapies and holistic approaches to manage cancer cachexia effectively." Active biotech and pharma companies
ihjn 8faqwhnutpp
MRK
8 May 24
biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention
ac6vfz18wr083qvye67drts6qy1or053g2r02vfwmjbhhfy3txz0h6
ABBV
ATNM
AZN
8 May 24
to enhance their portfolios with innovative cancer therapies. Most recently, Swiss pharmaceutical giant Novartis
rn24hki9hbazklhkg3tbo5tuarhr51vqmbsf82gfenteminxad6 mn2df
CTMX
MRK
7 May 24
design principles behind CX-801 integrate over a decade of continuous innovation and experience at CytomX in masking potent biologic therapies
gklc5fkcs yuh55guoltfbq3kdtqjmwdnp6qjesf2jqhvp
AMGN
CASI
JAZZ
7 May 24
the leadership of Scott Plesha as Chief Executive Officer. Pelthos is focused on the commercialization of innovative, safe, and efficacious therapeutic products